Chemoinformaics analysis of 12-Chloro-19,20-dihydroakuammicine
| Molecular Weight | 532.674 | nRot | 4 |
| Heavy Atom Molecular Weight | 488.322 | nRig | 32 |
| Exact Molecular Weight | 532.304 | nRing | 6 |
| Solubility: LogS | -4.309 | nHRing | 2 |
| Solubility: LogP | 2.853 | No. of Aliphatic Rings | 6 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
| Atoms Count | 82 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 38 | No. of Aromatic Carbocycles | 0 |
| nHetero | 8 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 2 | No. Saturated Carbocycles | 4 |
| No. of Hydrogen atom | 44 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 30 | No. of Saturated Rings | 5 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 8 | No. of Arom Bond | 0 |
| nHA | 8 | APOL | 85.8549 |
| nHD | 2 | BPOL | 52.8211 |
| QED | 0.491 |
| Synth | 6.477 |
| Natural Product Likeliness | 2.534 |
| NR-PPAR-gamma | 0.239 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.903 |
| Pgp-sub | 0.054 |
| HIA | 0.413 |
| CACO-2 | -5.168 |
| MDCK | 0.0000217 |
| BBB | 0.248 |
| PPB | 0.964865 |
| VDSS | 1.701 |
| FU | 0.0295884 |
| CYP1A2-inh | 0.001 |
| CYP1A2-sub | 0.961 |
| CYP2c19-inh | 0.009 |
| CYP2c19-sub | 0.835 |
| CYP2c9-inh | 0.038 |
| CYP2c9-sub | 0.134 |
| CYP2d6-inh | 0.005 |
| CYP2d6-sub | 0.398 |
| CYP3a4-inh | 0.21 |
| CYP3a4-sub | 0.201 |
| CL | 13.613 |
| T12 | 0.081 |
| hERG | 0.009 |
| Ames | 0.039 |
| ROA | 0.938 |
| SkinSen | 0.014 |
| Carcinogencity | 0.107 |
| EI | 0.008 |
| Respiratory | 0.978 |
| NR-Aromatase | 0.854 |
| Antiviral | Yes |
| Prediction | 0.716358 |